Using a modified yeast two-hybrid system to screen for chemical GEF inhibitors

Methods in Molecular Biology

Volumn 928, Issue , 2012, Pages 81-95

  Blangy, Anne ^a   Fort, Philippe ^b,c  

^a UNIV MONTPELLIER   (France)

^b Centre National de la Recherche Scientifique   (France)

^c CNRS   (France)

Author keywords

Chemicals; Rho signaling; RhoGEF; Screening; Two hybrid

Indexed keywords

EID: 84868581047     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-62703-008-3_7     Document Type: Article

References (17)

1. Shirai H, Autieri M, Eguchi S (2007) Small GTP-binding proteins and mitogen-activated protein kinases as promising therapeutic targets of vascular remodeling. Curr Opin Nephrol Hypertens 16: 111-5
2. Fritz G, Just I, Kaina B (1999) Rho GTPases are over-expressed in human tumors. Int J Cancer 81: 682-7
3. Bosco EE, Mulloy JC, Zheng Y (2009) Rac1 GTPase: a "Rac" of all trades. Cell Mol Life Sci 66: 370-4
4. Boureux A, Vignal E, Faure S, Fort P (2007) Evolution of the Rho family of ras-like GTPases in eukaryotes. Mol Biol Evol 24: 203-16 (Pubitemid 46026295)
5. Rossman KL, Der CJ, Sondek J (2005) GEF means go: turning on RHO GTPases with gua-nine nucleotide-exchange factors. Nat Rev Mol Cell Biol 6: 167-80 (Pubitemid 40215811)
6. Meller N, Merlot S, Guda C (2005) CZH proteins: a new family of Rho-GEFs. J Cell Sci 118: 4937-46 (Pubitemid 41672426)
7. Diaz-Flores E, Shannon K (2007) Targeting oncogenic Ras. Genes Dev 21: 1989-92 (Pubitemid 47267284)
8. Vega FM, Ridley AJ (2008) Rho GTPases in cancer cell biology. FEBS Lett 582: 2093-101
9. Lazer G, Katzav S (2010) Guanine nucleotide exchange factors for RhoGTPases: Good therapeutic targets for cancer therapy? Cell Signal 23: 969-79
10. Leonard DA, Evans T, Hart M, Cerione RA, Manor D (1994) Investigation of the GTP-binding/GTPase cycle of Cdc42Hs using fluorescence spectroscopy. Biochemistry 33: 12323-8 (Pubitemid 24328053)
11. Sander EE, van Delft S, ten Klooster JP, Reid T, van der Kammen RA, Michiels F, Collard JG (1998) Matrix-dependent Tiam1/Rac signaling in epithelial cells promotes either cell-cell adhesion or cell migration and is regulated by phosphatidylinositol 3-kinase. J Cell Biol 143: 1385-98 (Pubitemid 28559838)
12. Zheng Y, Hart MJ, Cerione RA (1995) Guanine nucleotide exchange catalyzed by dbl oncogene product. Methods Enzymol 256: 77-84
13. De Toledo M, Colombo K, Nagase T, Ohara O, Fort P, Blangy A (2000) The yeast exchange assay, a new complementary method to screen for Dbl-like protein specificity: identification of a novel RhoA exchange factor. FEBS Lett 480: 287-92
14. Blangy A, Bouquier N, Gauthier-Rouviere C, Schmidt S, Debant A, Leonetti JP, Fort P (2006) Identification of TRIO-GEFD1 chemical inhibitors using the yeast exchange assay. Biol Cell 98: 511-22 (Pubitemid 44383368)
15. Bouquier N, Vignal E, Charrasse S, Weill M, Schmidt S, Leonetti JP, Blangy A, Fort P (2009) A cell active chemical GEF inhibitor selectively targets the Trio/RhoG/Rac1 signaling pathway. Chem Biol 16: 657-66
16. Vives V, Laurin M, Cres G, Larrousse P, Morichaud Z, Noel D, Cote JF, Blangy A (2011) The Rac1 exchange factor Dock5 is essential for bone resorption by osteoclasts. J Bone Miner Res 26(5): 1099-110
17. Vignal E, Blangy A, Martin M, Gauthier-Rouviere C, Fort P (2001) Kinectin is a key effector of RhoG microtubule-dependent cellular activity. Mol Cell Biol 21: 8022-34 (Pubitemid 33051793)